News

Article

AMRI to be Acquired by The Carlyle Group

The company will be acquired for $21.75 per share in cash.

On June 6, 2017, AMRI announced that it has signed a definitive agreement to be acquired by affiliates of The Carlyle Group for $21.75 per share in cash. The agreement was unanimously approved by AMRI's Board of Directors, which has recommended that the shareholders vote in favor of the transaction.

Closing of the transaction is subject to customary closing conditions. It is anticipated that the special meeting of AMRI's stockholders to vote on the transaction will be held in the third quarter of 2017, and if the transaction is approved, the merger would be expected to close shortly thereafter.

Source: AMRI

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content